Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells

被引:240
作者
Evers, R
Zaman, GJR
vanDeemter, L
Jansen, H
Calafat, J
Oomen, LCJM
Elferink, RPJO
Borst, P
Schinkel, AH
机构
[1] NETHERLANDS CANC INST,DIV MOLEC BIOL,1066 CX AMSTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,DIV CELL BIOL,AMSTERDAM,NETHERLANDS
[3] NETHERLANDS CANC INST,DIV BIOPHYS,AMSTERDAM,NETHERLANDS
[4] UNIV AMSTERDAM,EC SLATER INST BIOCHEM RES,1066 CX AMSTERDAM,NETHERLANDS
[5] UNIV AMSTERDAM,ACAD MED CTR,DEPT GASTROENTEROL,1105 AZ AMSTERDAM,NETHERLANDS
关键词
multidrug resistance; reversal agents; glutathione S-conjugate; GS-X; pump sorting;
D O I
10.1172/JCI118535
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S-conjugate S-(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1-transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance.
引用
收藏
页码:1211 / 1218
页数:8
相关论文
共 35 条
[1]  
ALMQUIST KC, 1995, CANCER RES, V55, P102
[2]  
BURGER H, 1994, LEUKEMIA, V8, P990
[3]  
COLE SPC, 1994, CANCER RES, V54, P5902
[4]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[5]  
CORDONCARDO C, 1989, BIOCHEM J, V256, P959
[6]   CLINICAL PHARMACOKINETICS OF PROBENECID [J].
CUNNINGHAM, RF ;
ISRAILI, ZH ;
DAYTON, PG .
CLINICAL PHARMACOKINETICS, 1981, 6 (02) :135-151
[7]  
DIVIRGILIO F, 1988, BICOH J, V256, P9559
[8]   HEPATOBILIARY TRANSPORT OF GLUTATHIONE AND GLUTATHIONE CONJUGATE IN RATS WITH HEREDITARY HYPERBILIRUBINEMIA [J].
ELFERINK, RPJ ;
OTTENHOFF, R ;
LIEFTING, W ;
DEHAAN, J ;
JANSEN, PLM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :476-483
[9]   GLUTATHIONE-CONJUGATE TRANSPORT BY HUMAN COLON ADENOCARCINOMA CELLS (CACO-2 CELLS) [J].
ELFERINK, RPJO ;
BAKKER, CTM ;
JANSEN, PLM .
BIOCHEMICAL JOURNAL, 1993, 290 :759-764
[10]  
FLENS MJ, 1994, CANCER RES, V54, P4557